---
$id: https://graph.org.ai/products/commodity/51162728
$type: Product
source: UNSPSC
code: "51162728"
title: "Naphazoline"
class: "51162700"
classTitle: "Decongestants, expectorants, and mucolytics"
family: "51160000"
familyTitle: "Drugs affecting the respiratory tract"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Naphazoline

**UNSPSC Code**: 51162728
**Class**: [Decongestants, expectorants, and mucolytics](Decongestants, expectorants, and mucolytics.mdx)
**Family**: [Drugs affecting the respiratory tract](../Drugs affecting the respiratory tract.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an alpha-adrenergic agonist with the molecular formula C14H14N2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) H231GF11BV, chemically known as 4,5-dihydro-2-(1-naphthylmethyl)imidazole but more generally known as naphazoline, which bears US NIH Compound Identifier 4436. European Medicines Agency schedules Naphazoline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09154MIG. The term NAPHAZOLINE is an International Non-Proprietary Name. World Health Organization schedules naphazoline in its Anatomical Therapeutic Chemical (ATC) Classification. NAPHAZOLINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule naphazoline under HS 29332990 and SITC 51573. As of Q4 2014, NAPHAZOLINE remains US FDA's Preferred Term for this commodity. Naphazoline bears US NLM identifiers UMLS ID C0027373 and NCI Concept Code C61856. SMILES: N1C(=NCC1)CC1C2C(CCC1)CCCC2.

